Last month, the drug industry was abuzz with reports that Sanofi-Aventis was set to buy up Bristol-Myers Squibb. The move would make Paris-based Sanofi the worlds second-largest drug maker, after Pfizer. And although talks between the two companies are said to have broken down, they could yet be revived once a key patent dispute involvin both companies has been settled.
展开▼
